Publications by authors named "Barbara Lenzi"

Claim this Profile
B
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities.
Simone Rossi, Elisa Andrini, Rita Rinaldi, Tania Silvestri, Maria Giovanna Formelli, Barbara Lenzi

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy.
Andrea De Giglio, Elisa Tassinari, Arianna Zappi, Alessandro Di Federico, Barbara Lenzi

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: a case report within the experience of a single institution.
Alessandro Di Federico, Elisa Andrini, Monia Sisi, Giacomo Nuvola, Giuseppe Lamberti, Barbara Lenzi

Anticancer Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (HCC) with orbital metastases: a case report.
Daria M Filippini, Alessandro Di Federico, Barbara Lenzi, Elisabetta Nobili, Stefano Brocchi

Ann Palliat Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
Alessandro Di Federico, Giacomo Nuvola, Monia Sisi, Barbara Lenzi, Elisabetta Nobili

Anticancer Drugs· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
Maurizio Biselli, Annagiulia Gramenzi, Barbara Lenzi, Marco Dall'Agata, Monica Loreta Pierro

Clin Gastroenterol Hepatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Edoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, Matteo Brunacci, Barbara Lenzi

Hepatology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Intermediate stage treatment: Is TACE enough?
Anna Pecorelli, Barbara Lenzi, Franco Trevisani,

Liver Int· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
Anna Pecorelli, Barbara Lenzi, Annagiulia Gramenzi, Francesca Garuti, Fabio Farinati

Liver Int· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolutionary scenario of hepatocellular carcinoma in Italy: an update.
Laura Bucci, Francesca Garuti, Barbara Lenzi, Anna Pecorelli, Fabio Farinati

Liver Int· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo hepatocellular carcinoma of liver allograft: a neglected issue.
Franco Trevisani, Francesca Garuti, Alessandro Cucchetti, Barbara Lenzi, Mauro Bernardi

Cancer Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis.
Franco Trevisani, Antonio Di Micoli, Andrea Zambruni, Maurizio Biselli, Valentina Santi, Barbara Lenzi

Liver Int· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis